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The aim of this study was to evaluate the effects of leukocyte- and platelet-rich fibrin (L-PRF) on the pain and soft tissue healing
after tooth extractions. Twenty-six patients (9 males and 17 females) were treated with multiple extractions (2 to 8), with a total
of 108 extractions. This was an exploratory single blinded randomized clinical trial with a split-mouth design. The pain after the
surgery was assessed in each patient by the VAS scale (1 to 10) at intervals of 24-48-72-96 hours.The soft tissue healing was clinically
evaluated at 3, 7, 14, and 21 days after surgery by the same examiner surgeon, using the modified Healing Index (4 to 12). The mean
value of postextraction painwas 3.2± 0.3 in the experimental sides and 4.1± 0.1 in the control sides. After 7 days from the extractions,
the values of modified Healing Index in the experimental and control groups were, respectively, 4.8 ± 0.6 and 5.1 ± 0.9. The use of
L-PRF in postextraction sockets filling can be proposed as a useful procedure in order to manage the postoperative pain and to
promote the soft tissue healing process, reducing the early adverse effects of the inflammation.
1. Introduction
Many studies revealed that platelet concentrates for surgical
use can be used as efficient adjuvants for tissue repair [1–
5]. The growth factors (particularly platelet-derived growth
factors (PDGF), transforming growth factors (TGF-𝛽), and
vascular endothelial growth factors (VEGF)) and the other
molecules (fibrinogen, fibronectin, and vitronectin) con-
tained in platelets (𝛼-granules) give to these products the
ability to modulate many phases of the healing process like
the hemostasis and the neoangiogenesis [6]. The clinical
results of these products are interesting but remain quite
mixed and controversial in the literature, depending on the
kind of preparation [7–10]. Platelet concentrates are classified
into 4 main families depending on their leukocyte and fibrin
content: pure platelet-rich plasma (P-PRP), leukocyte- and
platelet-rich plasma (L-PRP), pure platelet-rich fibrin (P-
PRF), and leukocyte- and platelet-rich fibrin (L-PRF) [11].
Each family of products has different aspect, biological con-
tent, and potential application [12].
The PRPs were already tested in many oral surgery
applications, with mixed results depending on the kind of
preparations [13–16]. Numerous protocols have attempted to
optimize the preparation of the autologous factors, using var-
ious performances standards and centrifugation parameters
[17, 18]. Several authors demonstrated the effectiveness of
some PRP types during tooth extractions to stimulate soft
tissue healing andwound control [19, 20] and in prevention of
postoperative bleeding in anticoagulated patients undergoing
oral surgery. However, these PRP techniques remain quite
complex and expensive on a daily use basis, and their usemay
not be justified for daily oral surgery applications [13, 14].
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On the other hand, L-PRF represents a more recent gen-
eration of platelet concentrates. The development of L-PRF
is very significant in oral andmaxillofacial surgery, withmany
validated applications in periodontal surgery [13, 21] and
implant dentistry [14–22]. L-PRF is easy and inexpensive to
prepare for frequent use in private practice, and it exists in
the form of L-PRF clots or membranes (after compression).
The membrane releases a significant quantity of autologous
growth factors (particularly PDGF-AB, TGF𝛽, and VEGF)
[23], cytokines, and healing proteins (fibronectin, etc.) during
more than 7 days in vitro [24], while other platelet gels
dissolve in vitro in 3 days [12]. In another study, when com-
pared with a procedure for platelet-rich plasma (PRP), L-PRF
released more than 15-fold VEGF and more than 2-fold
TGF𝛽1 [25]. According to the literature, L-PRF was a useful
tool in postextraction hemostasis control [26] and in preven-
tion of hemorrhagic complications in cardiopathic patients
[27].
The aim of this study is to evaluate the effectiveness of L-
PRF to improve the soft tissues healing and to reduce pain
after tooth extractions.
2. Materials and Methods
2.1. Study Population. From January 2012 to July 2013 at the
Unit of Oral Surgery and Implantology of the University
of Naples “Federico II,” 26 healthy patients were selected,
including 9 males and 17 females with a mean age of 53 ± 4
years. The selected patients were nonsmokers or light smok-
ers (<5/day); they did not have systemic diseases that could
interfere with the healing process (such as diabetes, liver dis-
ease, heart disease, or immune-disorders) or diseases of the
oral mucosa. The study was designed as a prospective split-
mouth trial on patients who needed bilateral paired dental
extractions; on the side chosen to be the study side, the sock-
etswere filledwith L-PRF,whereas on the other side (control),
they were allowed to undergo natural healing. Test and
control sites were chosen with coin toss randomization. This
cross-sectional split-mouth research study was conducted in
accordance with the requirements of Helsinki Declaration of
1975 as revised in 2008. Patients were verbally informed about
the sample to be taken and gave their written consent. The
patients who did not sign the agreement and also the patients
with poor oral hygiene, patients with local infections of the
soft tissues, patients undergoing bisphosphonates therapy,
patients irradiated to the jaws in the past, and patients with
psychiatric illness or pregnant patients were excluded from
the study.
2.2. Surgical Procedure. An alveolar nerve block infiltration
was administrated with local or regional anesthesia, depend-
ing on the dental arch, using 2% mepivacaine. Mepivacaine
does not contain epinephrine, so it was used to prevent
restriction of the blood supply. To prevent interference
with the healing process, no intraligamentous or intrapap-
illary infiltration was made. The teeth were extracted in
a nontraumatic manner without elevation of full-thickness
flaps and preserving the buccal and lingual walls of the
alveolar sockets in order to minimize the possible trauma
Figure 1: Presurgery clinical occlusal view. For orthodontic motive,
this patient needed the bilateral extraction of the upper first
premolars.
Figure 2: The postextraction sockets.
and to give adequate support to the L-PRF filling (Figures
1 and 2). All extraction sites were simple with alveolar
walls preserved. All alveolar sockets were sutured with a
3/0 Vicryl (Ethicon/Johnson & Johnson, Somerville, NJ,
USA). Each patient also served as the control (split-mouth
design): a socket was treated with L-PRF application (study
socket) whereas the other (control socket) had to undergo
natural healing by clot formation without socket filling
(Figure 3). The number of paired extractions per patient
ranged from 2 to 4 for a total of 108 extractions. Indica-
tion for tooth extraction included root or crow fractures,
residual roots, no restorable caries, periapical granuloma,
and orthodontic reasons. Patients showing anatomic and
pathologic conditions not comparable between the study and
control sites were excluded as study subject. Antibiotic pro-
phylaxis was undertaken (amoxicillin 875mg and clavulanic
acid 125mg) starting 2 days before surgery up to 3 days
after it.
2.3. L-PRF Preparation Protocol. The L-PRF was prepared
through a single centrifugation of blood according to the pro-
tocol of Dohan Ehrenfest et al. (now marketed as Intra-Spin
L-PRF kit, Intra-Lock, Boca-Raton, FL, USA) for a period
of 12 minutes at 2700 rpm. Blood was taken in 9mL tubes,
30 minutes before the surgery, immediately centrifuged, and
used for the filing of the experimental sites. The total amount
of blood collected (from 18mL to 54mL) was related to the
number of tooth extractions, in order to obtain the complete
filling of the sockets with the L-PRF. After centrifugation,
each L-PRF clot was separated from the portion of red blood
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Table 1
Number of
patients
Number of paired
extractions per patient Tooth extracted
10 1 Premolar
7 2 Canine/premolar/molar
6 3 Canine/premolar/molar
3 4 Canine/premolar/molar
Figure 3: The upper right socket (study site) was filled with L-
PRF, while the upper left socket (control site) had to follow natural
healing. Both sites were sutured.
cells (red thrombus), obtaining a fibrin clot with a red small
portion in order to include the “buffy” coat richer in large
leucocytes [24]. The L-PRF clot was condensed and modeled
on a sterile surgical plate before the application in the sockets
[24].
L-PRF was used within 60 minutes after the preparation.
It was accurately positioned in the extraction sites and
stabilized with a resorbable suture. In the control sites, the
same suture was used (Figure 3). All patients were advised to
follow soft and liquid diet, avoiding hot food in the following
hours. In all cases, the sutures were removed after one week.
Table 1 reports the number and the type of paired extractions
per patient.
2.4. Study Variables and Statistical Methods. The predictor
variable was the treatment group status: L-PRF versus control
socket. The outcome variables of interest were as follows:
pain, postsurgical complications to soft and hard tissues, and
the Healing Index modified.
A 10-point visual analog scale (VAS) with a score of 0 that
equals “no pain” and a score of 10 that equals “very severe
pain” was used by the same patient to assess the postoperative
pain at 24, 48, and 72 hours. Between groups comparisons for
VAS outcomes were carried out by means of univariate anal-
ysis of variance, considering the group (i.e., PRF versus CTR)
and the recording time point as factors and VAS score as
dependent variable.
The quality of the socket soft tissue healing was clin-
ically evaluated at 3, 7, 14, and 21 days after surgery by
an examiner surgeon, using the Healing Index modified
[28] which involved 3 scoring levels for each of the four
parameters considered: bleeding, suppuration, tissue color,
and consistency of the healing tissue.The scoring scale ranged
from 4, corresponding to excellent healing, to 12, indicating
Table 2
Healing Index 3 days 7 days 14 days 21 days
L-PRF 4.8 ± 0.6 4.5 ± 0.5 4.2 ± 0.2 4.1 ± 0.1
CTRL 5.1 ± 0.9 4.9 ± 0.3 4.3 ± 0.3 4.2 ± 0.2
𝑃 0.197 0.05 0.01 0.0002
L-PRF = study site; CTRL = control site.
Figure 4:Clinical occlusal view 3 days after surgery. In the study site,
the epithelialization process was more advanced than in the control
site. In the study site, the inflammatory reaction was reduced.
severely impaired healing.TheWilcoxon signed-rank test for
comparison of 2 correlated samples matched pairs with the
level of significance predetermined at 0.05 was used.
3. Results
All patients completed the study. No cases of bleeding,
infection, alveolar osteitis, or other surgical complications
were reported.
Regarding the postextraction pain, patients enrolled in
the study reported a mean value of the study sites of 3.2± 0.3,
which is lower (𝑃 < 0.0001) than the mean value of the
control sites (4.5 ± 0.7), with a statistical difference average of
0.9 ± 0.3. The VAS score was nearly equal for the 2 sides after
4 days (decreasing to 0).
Results concerning the healing of the socket are reported
in Table 2. Comparisons between values relative to the study
and control sides showed better healing and faster socket
closure for the side treated with L-PRF, with differences
statistically significant at days 3 and 7 (Figures 4 and 5).
4. Discussion
This study was designed to test the efficacy of L-PRF in foster-
ing socket healing after tooth extractions.The 26 split-mouth
case control extractions that constituted our study were
statistically enough to prove the ability of L-PRF to improve
the early healing phases (hemostasis and epithelial closure),
reducing the inflammatory process and the risk of infection.
The reported results of the experimental sites showed, in the
first 7 days after the tooth extractions, a fast evolution of the
healing and a positive effect on pain. After a week, minor
differences between the two groups are reported (Figures
6 and 7). These effects could be related to the biochemical
and structural features of the L-PRF [29], which collects a
large quantity of leukocytes (about 60% of the initial blood
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Figure 5: Clinical occlusal views 7 days after surgery. The sutures
were removed. Both postextraction socket cavities presented a
decreased volume and appeared epithelialized.
Figure 6: Clinical follow-up at 14 days after surgery. Both postex-
traction sockets were completely closed with the soft tissues.
harvest) and platelets embedded in a fibrin matrix [30, 31].
The fibrin architecture of L-PRF, constituted by connected
trimolecular junctions (or equatorial), due to a slow poly-
merization of the platelet concentrate and due to the absence
of heterologous thrombin, induces a flexible fibrin network,
able to promote the gradual release of growth factors and
leukocytes migration. The fibrin membrane promotes the
mechanical protection of the surgical site and, biologically,
it interacts with the physiological mechanisms of healing
favoring the angiogenesis [13, 14]. The fibrin induces the
expression of 𝛼v-𝛽3 integrin by endothelial cells, allowing
the links with structural proteins, such as fibronectin and
vitronectin, supporting the process of formation of capillaries
[12]. In relation to the previous properties, the fibrin also
allows the association of some growth factors, such as FGFb
(fibroblast growth factor basic) and PDGF (platelet-derived
growth factor) involved in the angiogenic process and useful
as chemotactic factors, favoring diapedesis of white blood
cells [12].The immunological properties of the L-PRF, result-
ing from its content in leukocytes, could be useful to prevent
the surgical site infections, such as postextraction alveolitis,
with a consequent reduction of the inflammation symptoms.
The presence of leukocytes is a very important parameter to
stimulate healing and wound control [32].
Themain limitation of this exploratory study was that the
extraction sites were voluntarily very simple, with all alveolar
walls preserved. It allowed standardizing the study easily to
Figure 7: At 21 days after surgery, both postextraction healing sites
were completely closed with the soft tissues.
reach a very clean result, but it does not reflect the real
strength and advantages of L-PRF. This material is particu-
larly useful and efficient in complex situations, when some
walls are destroyed and the bone regeneration is difficult, but
an accurate split-mouth study with this kind of cases is virtu-
ally impossible to standardize. It is however the needed next
step of evaluation and validation of the use of L-PRF during
tooth extractions.
5. Conclusion
Even if the selected samples are limited, the reported results
suggested that the use of L-PRF in postextraction sockets
filling is an efficient and useful procedure in order to manage
the postoperative pain and to enhance the alveolar soft tissue
healing process, especially in the first days after the extrac-
tions, reducing the early adverse effects of the inflammation.
This study represents a preliminary clinical trial, which could
be used as baseline for further histologic studies.
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